Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 26.54 billion as of March 31, 2025. Its market cap has decreased by -16.55% in one year.

Market Cap

26.54B

Enterprise Value

27.36B

Revenue

4.62B

Ranking

n/a

PE Ratio

1.15

Stock Price

12.36

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 26.54B, an increase of 1,156.74%. That is a compound annual growth rate of 31.48%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	27.23B	29.07%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	22.03B	-33.64%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	223.66B
Hansoh Pharmaceutical Group Company	140.05B
WuXi Biologics	109.81B
JD Health International	105.91B
Alibaba Health Information Technology	77.19B
Innovent Biologics	75.68B
Akeso	66.96B
Sino Biopharmaceutical	66.70B

Market Cap Rankings